SEC Company Response from Hana Biosciences Inc (CIK 0001140028) — Jan 18, 2005
Hana Biosciences Inc (CIK 0001140028)
Date: Jan. 18, 2005 · CIK: 0001140028 · Accession: 0001144204-05-001468
AI Filing Summary & Sentiment
File numbers found in text: 333-118426
Letter
VIA EDGAR U.S. Securities and Exchange Commission Judiciary Plaza 450 5th Street, N.W. Washington, D.C. 20549 Attention: Sonia Barros, Esq.
Re: Hana Biosciences, Inc. (the "Company") Registration Statement on Form SB-2 File No. 333-118426
Dear Ms. Barros:
On behalf of the Company, the undersigned respectfully requests that the above-referenced Registration Statement be declared effective at 4:00 p.m., Washington, D.C. time, on January 18, 2005, or as soon thereafter as is practicable.
On behalf of the Company, the undersigned hereby acknowledges the following:
1. Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
2. The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3. The Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
HANA BIOSCIENCES, INC.
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
HANA BIOSCIENCES, INC.
400 OYSTER POINT BLVD., SUITE 215
SOUTH SAN FRANCISCO, CA 94080
January 18, 2005
VIA EDGAR
U.S. Securities and Exchange Commission
Judiciary Plaza
450 5th Street, N.W.
Washington, D.C. 20549
Attention: Sonia Barros, Esq.
Re: Hana Biosciences, Inc. (the "Company")
Registration Statement on Form SB-2
File No. 333-118426
Dear Ms. Barros:
On behalf of the Company, the undersigned respectfully requests that the
above-referenced Registration Statement be declared effective at 4:00 p.m.,
Washington, D.C. time, on January 18, 2005, or as soon thereafter as is
practicable.
On behalf of the Company, the undersigned hereby acknowledges the
following:
1. Should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the Commission
from taking any action with respect to the filing;
2. The action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from
its full responsibility for the adequacy and accuracy of the disclosure in the
filing; and
3. The Company may not assert this action as a defense in any proceeding
initiated by the Commission or any person under the federal securities laws of
the United States.
Sincerely,
HANA BIOSCIENCES, INC.
By: /s/ Russell L. Skibsted
---------------------------------------
Russell L. Skibsted
Vice President, Chief Financial Officer
</TEXT>
</DOCUMENT>